Skip to Main Content

Paper Details

Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature
29
2023
IFN, JAK, PD-1, RIPK, STAT, TANK-binding kinase 1, TBK1, TNF, Tumour, Tumour cells, cancer, cancers, caspase, immune-evasion gene, melanoma, patient, patient-derived organoids, patient-derived organotypic tumour spheroids, tumour
Author NameAffiliation
Caitlin E MillsHarvard Medical School
Keren YizhakInstitute of Technology
Gao ZhangThe Wistar Institute
Gao ZhangDuke University School of Medicine
Gao ZhangDuke University School of Medicine
Elena IvanovaDana-Farber Cancer Institute
Elena IvanovaBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
Elena IvanovaDana-Farber Cancer Institute
Elena IvanovaBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
David E FisherCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School
David E FisherCutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School
Nir HacohenMassachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School
Nir HacohenBroad Institute of MIT and Harvard
Nir HacohenMassachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School
Nir HacohenBroad Institute of MIT and Harvard
Peter K SorgerHarvard Medical School
  • 1 - 16

Datasets

Release 1.2